CJC-DAC 5mg/vial 1 Vial by Master Pharma

Usage

1. Reconstitute the vial: Add bacteriostatic water to the 5 mg lyophilised vial; swirl gently until fully dissolved. Refrigerate immediately at 2–8 °C.
2. Calculate your working dose: For 1,000 mcg from a 5 mg vial reconstituted with 2.5 mL, draw 0.5 mL per injection — label the vial with reconstitution date.
3. Prepare Ipamorelin separately: Reconstitute Ipamorelin in its own vial; the two peptides can be drawn into the same syringe immediately before injection to minimise injection sites.
4. Select injection windows: Administer the combined Ipamorelin + CJC-1295 DAC syringe at the pre-sleep window on CJC-1295 DAC dosing days; inject Ipamorelin alone at remaining daily windows.
5. Inject subcutaneously: Rotate sites — abdomen, flanks, or upper thigh — using a 29–31 gauge syringe; inject fasted for optimal somatotroph response.
6. Track and adjust: Log each injection window and run an IGF-1 blood panel at week 4 to confirm GH axis response; adjust dose or frequency based on results before continuing.

Warnings

Frequently asked questions

Why stack CJC-1295 DAC with Ipamorelin instead of using either peptide alone?

Stacking CJC-1295 DAC with Ipamorelin produces synergistic GH output because the two peptides act on separate but complementary receptors — GHRH receptors and ghrelin receptors respectively. Research co-administration models show GH pulse amplitude two to three times greater than monotherapy with either compound. CJC-1295 DAC primes the pituitary continuously while Ipamorelin triggers discrete, somatostatin-sensitive pulses, maintaining a physiological pulsatile GH pattern.

How many times per day should Ipamorelin be injected when running it alongside CJC-1295 DAC?

Ipamorelin is typically injected two to three times daily in the classic stack — commonly at pre-sleep, post-workout, and optionally morning windows. CJC-1295 DAC, by contrast, is administered only once or twice per week because its albumin-binding modification dramatically extends its half-life. Synchronising an Ipamorelin injection with the CJC-1295 DAC injection on dosing days maximises peak GH pulse amplitude.

What is the optimal time to take the Mod GRF / CJC-1295 and Ipamorelin injections for GH release?

The pre-sleep injection is widely regarded as the highest-priority window because endogenous GH secretion peaks during slow-wave sleep. A post-workout injection capitalises on exercise-induced GHRH sensitivity. Morning injections are optional and fasted administration is preferred for all windows, as elevated blood glucose blunts somatotroph responsiveness to GHRH stimulation.

How do you reconstitute and store Master Pharma CJC-1295 DAC 5mg/vial?

Add 1–2 mL of bacteriostatic water to the lyophilised 5 mg vial by directing the solvent slowly down the inner vial wall, then swirl gently — never vortex. Refrigerate the reconstituted vial at 2–8 °C and use within 28 days. Before reconstitution, store the lyophilised vial at 2–8 °C; the intact lyophilisate tolerates short ambient excursions but should not be exposed to heat or direct light.

Is the 5mg/vial concentration of CJC-1295 DAC practical for a full GH-stack cycle?

Yes — at 5 mg per vial, a typical weekly dose of 1,000–2,000 mcg (1–2 mg) means each vial covers two to five weekly injections depending on dose selection. This makes the 5 mg format economical and easy to titrate for users who want conservative entry-level dosing or who prefer fresher reconstituted solutions by working through smaller volumes within the 28-day refrigerated window. (2) angle_used

Manufacturer

Batch-to-batch consistency is the defining quality metric for Master Pharma's CJC-1295 DAC 5 mg/vial line: every production lot is subjected to HPLC purity quantification and LAL endotoxin testing independently, with results compared against prior-batch reference standards before release is authorised. This comparative batch-release process means that certificate values for purity, identity, and endotoxin load are cross-validated across sequential production runs — not assessed in isolation — giving distributors and end users a statistically meaningful consistency record rather than a single-point pass/fail result. Lyophilisation parameters are held constant across batches to ensure that residual moisture and cake structure remain within defined tolerances, directly supporting reconstitution reproducibility in research settings.